欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/1608/004
药品名称Everolimus Teva
活性成分
    • Everolimus 10.0 mg
剂型Tablet
上市许可持有人Teva Sweden AB Box 1070 251 10 Helsingborg Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Germany (DE)
      Everolimus-ratiopharm 10 mg Tabletten
    • Denmark (DK)
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      Everolimus ratiopharm 10 mg Tabletten
    • France (FR)
    • Portugal (PT)
    • Greece (GR)
      EVEROLIMUS/TEVA
    • Norway (NO)
      Everolimus Teva
    • Latvia (LV)
      Everolimus Teva 10 mg tabletes
    • Bulgaria (BG)
      Everolimus Teva
    • Czechia (CZ)
      Everolimus Teva 10 mg tablety
    • Slovakia (SK)
      Everolimus Teva 10 mg
    • Croatia (HR)
      Everolimus Pliva 10 mg tablete
许可日期2017/05/03
最近更新日期2025/03/24
药物ATC编码
    • L01EG02 everolimus
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase